2015-07326. Office of Dietary Supplements VDSP Commutability Study 2  

  • Start Preamble

    SUMMARY:

    NIH Office of Dietary Supplements (ODS) and the National Institute of Standards and Technology (NIST), in collaboration with the College of American Pathologists (CAP) and Vitamin D External Quality Assessment Scheme (DEQAS), announce that as part of the Vitamin D Standardization Program (VDSP), they are recruiting laboratories to participate in a study of the commutability of pooled serum samples used in assays to measure total 25-hydroxyvitamin D [25(OH)D].

    DATES:

    The expected start date for the study is June 2015.

    ADDRESSES:

    For more information about the study and to let us know if you are interested in participating, please contact us at: vdsp@mail.nih.gov.

    Start Further Info

    FOR FURTHER INFORMATION CONTACT:

    Drs. Johanna Camara, NIST, and Christopher Sempos, ODS, Director and Co-Director, respectively, for the VDSP Commutability Study 2. Email: VDSP@mail.nih.gov.

    End Further Info End Preamble Start Supplemental Information

    SUPPLEMENTARY INFORMATION:

    The objective of the study is to promote the standardized measurement of total 25(OH)D by evaluating the commutability of NIST Standard Reference Materials® (SRM) used as “trueness” controls and the materials used in the major Performance Testing/External Quality (PT/EQA) programs administered by CAP and DEQAS. Who Can Participate: (1) All commercial manufacturers of 25(OH)D assays (requests from manufacturers with assays in development will be considered); (2) Clinical and research laboratories using a commercial assay platform; (3) Laboratories for national/subnational nutrition surveys; and (4) Laboratories using in-house developed assays.

    For details about the study design and time lines, see the recently published paper in the February 2015 edition of Clinical Laboratory News, (https://www.aacc.org/​publications/​cln/​articles/​2015/​february/​vitamin-d-commutability-study).

    Start Signature

    Dated: March 24, 2015.

    Lawrence A. Tabak,

    Deputy Director, National Institutes of Health.

    End Signature End Supplemental Information

    [FR Doc. 2015-07326 Filed 3-31-15; 8:45 am]

    BILLING CODE 4140-01-P

Document Information

Published:
04/01/2015
Department:
National Institutes of Health
Entry Type:
Notice
Document Number:
2015-07326
Dates:
The expected start date for the study is June 2015.
Pages:
17441-17441 (1 pages)
PDF File:
2015-07326.pdf